Showing results (21-30 of 40) with videos related to
Sort By:
Pageof 4
Frontiers in Oncology|May 8, 2023
Impact of novel agent therapies on immune cell subsets and infectious complications in patients with relapsed/refractory multiple myelomaLukas John, Kaya Miah, Axel Benner, et al.Cancers|January 21, 2022
Two Decades of Active Surveillance for Prostate Cancer in a Single-Center Cohort: Favorable Outcomes after Transurethral Resection of the ProstateSarah Hagmann, Venkat Ramakrishnan, Alexander Tamalunas, et al.European Journal of Nuclear Medicine and Molecular Imaging|July 26, 2023
Application of an artificial intelligence-based tool in [18F]FDG PET/CT for the assessment of bone marrow involvement in multiple myelomaChristos Sachpekidis, Olof Enqvist, Johannes Ulén, et al.The Prostate|March 18, 2026
Exploring the Gut-Prostate Axis: Microbial Signatures Linked to Prostate Volume and Bladder FunctionJonathan Surber, Marie Lork, Yasser Morsy, et al.Molecular Cancer Research : MCR|May 3, 2022
Midkine Promotes Metastasis and Therapeutic Resistance via mTOR/RPS6 in Uveal MelanomaMargarete M Karg, Lukas John, Nasrin Refaian, et al.European Radiology|November 28, 2024
Splenic T2 signal intensity loss on MRI is associated with disease burden in multiple myelomaChristian Neelsen, Christos Sachpekidis, Lukas John, et al.Cells|May 24, 2024
Pre-Clinical Assessment of SAR442257, a CD38/CD3xCD28 Trispecific T Cell Engager in Treatment of Relapsed/Refractory Multiple MyelomaAnna Luise Grab, Peter S Kim, Lukas John, et al.Microorganisms|January 8, 2025
Towards Reliable Methodology: Microbiome Analysis of Fresh Frozen vs. Formalin-Fixed Paraffin-Embedded Bladder Tissue Samples: A Feasibility StudyDominik Enderlin, Uwe Bieri, Jana Gadient, et al.Blood Advances|August 17, 2022
Characterizing the role of the immune microenvironment in multiple myeloma progression at a single-cell levelCarolina Schinke, Alexandra M Poos, Michael Bauer, et al.Leukemia|October 11, 2023
High-throughput electron tomography identifies centriole over-elongation as an early event in plasma cell disordersSebastian Köhrer, Tobias Dittrich, Martin Schorb, et al.Pageof 4